These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 24690905

  • 1. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease.
    Sun M, Yang P, Du L, Yang Y, Ye J.
    PLoS One; 2014; 9(4):e93214. PubMed ID: 24690905
    [Abstract] [Full Text] [Related]

  • 2. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.
    Peng Z, Jiang S, Wu M, Zhou X, Wang Q.
    Mol Vis; 2017; 23():538-547. PubMed ID: 28761327
    [Abstract] [Full Text] [Related]

  • 3. Upregulated IRAK1 and IRAK4 promoting the production of IFN-γ and IL-17 in Behcet's disease.
    Sun M, Yang P, Yang Y, Ye J.
    Int Ophthalmol; 2018 Oct; 38(5):1947-1953. PubMed ID: 28780618
    [Abstract] [Full Text] [Related]

  • 4. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
    Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, Chen L, Zhou H, Huang X, Kijlstra A.
    J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.
    Li F, Yang P, Liu X, Wang C, Hou S, Kijlstra A.
    Arch Ophthalmol; 2010 Nov; 128(11):1449-54. PubMed ID: 21060047
    [Abstract] [Full Text] [Related]

  • 6. Increased IL-7 expression in Vogt-Koyanagi-Harada disease.
    Yang Y, Xiao X, Li F, Du L, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2012 Feb 27; 53(2):1012-7. PubMed ID: 22247488
    [Abstract] [Full Text] [Related]

  • 7. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L, Yang P, Zhou H, He H, Ren X, Chi W, Wang L, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Aug 27; 49(8):3475-82. PubMed ID: 18421089
    [Abstract] [Full Text] [Related]

  • 8. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.
    Chu M, Yang P, Hu R, Hou S, Li F, Chen Y, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2011 Sep 09; 52(10):7084-9. PubMed ID: 21810982
    [Abstract] [Full Text] [Related]

  • 9. Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
    Yi X, Yang P, Sun M, Yang Y, Li F.
    Mol Vis; 2011 Mar 09; 17():673-9. PubMed ID: 21403851
    [Abstract] [Full Text] [Related]

  • 10. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.
    Wang C, Tian Y, Lei B, Xiao X, Ye Z, Li F, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2012 Jul 10; 53(8):4668-75. PubMed ID: 22669715
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease.
    He Y, Wang C, Su G, Deng B, Ye Z, Huang Y, Yuan G, Aize K, Li H, Yang P.
    Br J Ophthalmol; 2018 Aug 10; 102(8):1167-1172. PubMed ID: 29699987
    [Abstract] [Full Text] [Related]

  • 13. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease.
    Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S.
    Curr Eye Res; 2001 Apr 10; 22(4):312-8. PubMed ID: 11462171
    [Abstract] [Full Text] [Related]

  • 14. Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment.
    Ye Z, Wang C, Tang J, Zhou Y, Bai L, Liu Y, Kijlstra A, Yang P.
    J Interferon Cytokine Res; 2015 Apr 10; 35(4):265-72. PubMed ID: 25343528
    [Abstract] [Full Text] [Related]

  • 15. Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease.
    Yang J, Hu J, Feng L, Yi S, Ye Z, Lin M, Liu X, Pu Y, Kijlstra A, Yang P, Li H.
    Ocul Immunol Inflamm; 2020 Apr 10; 28(2):200-208. PubMed ID: 30794473
    [Abstract] [Full Text] [Related]

  • 16. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
    Zhou Z, Tian Z, Zhang M, Zhang Y, Ni B, Hao F.
    Immunol Invest; 2018 Jul 10; 47(5):468-483. PubMed ID: 29611775
    [Abstract] [Full Text] [Related]

  • 17. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
    Commodaro AG, Peron JP, Genre J, Arslanian C, Sanches L, Muccioli C, Rizzo LV, Belfort R.
    Scand J Immunol; 2010 Jul 10; 72(1):31-7. PubMed ID: 20591073
    [Abstract] [Full Text] [Related]

  • 18. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion.
    Liu L, Yang P, He H, Lin X, Jiang L, Chi W, Zhao C, Zhou H.
    Br J Ophthalmol; 2008 Apr 10; 92(4):557-61. PubMed ID: 18245271
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.
    Xu M, Wang C, Tian Y, Kijlstra A, Yang P.
    Ocul Immunol Inflamm; 2014 Aug 10; 22(4):294-9. PubMed ID: 24329541
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease.
    Chang R, Yi S, Tan X, Huang Y, Wang Q, Su G, Zhou C, Cao Q, Yuan G, Kijlstra A, Yang P.
    Br J Ophthalmol; 2018 Feb 10; 102(2):282-290. PubMed ID: 28972028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.